Microneedles have attracted considerable attention in a wide range of transdermal biomedical applications, such as biosensing and drug delivery, owing to their advantages, including painlessness, minimal invasiveness and sustainability. However, the current challenge lies in the materials and fabrication methods used to produce microneedles with specific shapes, structures, and functions
Cytokines are small protein molecules that are secreted by cells in order to coordinate intercellular communication in response to inflammation or infection. These molecules therefore play a vital role in the innate immune response to infection and contribute to the activation of the adaptive immune response. Therefore, characterizing cytokine responses
Point-of-care testing technology has exceptional capabilities for detecting biomarkers for a wide range of diseases thanks to its speed, ease of use, efficiency and cost-effectiveness. One such POCT strategy is the lateral flow immunoassay. It is a well-established testing platform and a powerful tool for rapid,
Organoids are 3D microstructures that are cultured in vitro and derived from human pluripotent stem cells (hPSCs) or adult stem cells (AdSCs) obtained from healthy individuals or patients. They are capable of reproducing the cellular heterogeneity, structure, and function of human organs. Human 3D organoid systems allow the extremely detailed
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the launch of its new high-precision Polystyrene Cell Viability Standards. These microspheres can provide researchers and laboratory professionals with reliable and highly reproducible tools in biological cell controls for instrument calibration and assay validation.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has today announced the launch of its comprehensive OMV-Based Bacterial Vaccines Development services. This new platform that integrates synthetic biology with advanced bacterial genome editing can address the historical limitations of traditional vaccine platforms, offering
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its new Tumor Organoid & CAF Co-culture services to provide researchers with a more physiologically relevant in vitro tumor model, enabling a deeper understanding of tumor-stromal interactions and the
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the launch of its custom Enzyme-Conjugated Particles synthesis services. These particles are primarily polymer- and inorganic-based, and biomolecules and enzymes can be conjugated to them in different ratios for various applications. Due to
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its enhanced, one-stop AAV Vector Design services to support researchers in accelerating advancements in gene therapy and delivery, including the design, construction, and cloning of custom Adeno-Associated Virus (AAV)
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the launch and expanded availability of its cutting-edge Beads Based Multiplex Assay services for researchers to simultaneously measure up to 500 analytes from a single sample, significantly enhancing the efficiency and precision of preclinical
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of a comprehensive range of exosome modification products and services to support researchers in harnessing the unique potential of exosomes for targeted drug delivery, diagnostics, and advanced therapeutic applications. Exosomes are used
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced its custom nucleic acid delivery particle synthesis services for the advancement of gene therapy, gene editing, vaccines and immunotherapy. These new offerings, such as the synthesis of basic particles, can address the growing need for